Critical Role of cAMP-GEFII·Rim2 Complex in Incretin-potentiated Insulin Secretion*

Incretins such as glucagon-like peptide-1 and gastric inhibitory polypeptide/glucose-dependent insulinotropic peptide are known to potentiate insulin secretion mainly through a cAMP/protein kinase A (PKA) signaling pathway in pancreatic β-cells, but the mechanism is not clear. We recently found that the cAMP-binding protein cAMP-GEFII (or Epac 2), interacting with Rim2, a target of the small G protein Rab3, mediates cAMP-dependent, PKA-independent exocytosis in a reconstituted system. In the present study, we investigated the role of the cAMP-GEFII·Rim2 pathway in incretin-potentiated insulin secretion in native pancreatic β-cells. Treatment of pancreatic islets with antisense oligodeoxynucleotides (ODNs) against cAMP-GEFII alone or with the PKA inhibitor H-89 alone inhibited incretin-potentiated insulin secretion ∼50%, while a combination of antisense ODNs and H-89 inhibited the secretion ∼80–90%. The effect of cAMP-GEFII on insulin secretion is mediated by Rim2 and depends on intracellular calcium as well as on cAMP. Treatment of the islets with antisense ODNs attenuated both the first and second phases of insulin secretion potentiated by the cAMP analog 8-bromo-cAMP. These results indicate that the PKA-independent mechanism involving the cAMP-GEFII·Rim2 pathway is critical in the potentiation of insulin secretion by incretins.

[1]  E. Hooghe-Peters,et al.  Interplay of nutrients and hormones in the regulation of insulin release. , 1985, Endocrinology.

[2]  C. Lippe,et al.  Actions of vasopressin and isoprenaline on the ionic transport across the isolated frog skin in the presence and the absence of adenyl cyclase inhibitors MDL12330A and SQ22536. , 1991, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology.

[3]  S. Howell,et al.  The mode of action of adenosine 3':5'-cyclic monophosphate in mammalian islets of Langerhans. Preparation and properties of islet-cell protein phosphokinase. , 1972, The Biochemical journal.

[4]  J. Miyazaki,et al.  Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Drucker.  Glucagon-Like Peptides , 1998, Diabetes.

[6]  P. Sugden,et al.  Protein kinase activities in rat pancreatic islets of Langerhans. , 1979, The Biochemical journal.

[7]  S. Seino,et al.  Expression and complex formation of soluble N-ethyl-maleimide-sensitive factor attachment protein (SNAP) receptors in clonal rat endocrine cells , 1995, Neuroscience Letters.

[8]  D. Pipeleers,et al.  Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. , 2001, Diabetes.

[9]  T. Katada,et al.  Islet-activating protein. Enhanced insulin secretion and cyclic AMP accumulation in pancreatic islets due to activation of native calcium ionophores. , 1979, The Journal of biological chemistry.

[10]  B. Göke,et al.  Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. , 1995, Endocrine reviews.

[11]  F M Matschinsky,et al.  Ca2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. , 1987, Physiological reviews.

[12]  D. Drucker,et al.  Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Hermans,et al.  Glucose-, calcium- and concentration-dependence of acetylcholine stimulation of insulin release and ionic fluxes in mouse islets. , 1988, The Biochemical journal.

[14]  M. Hagiwara,et al.  Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. , 1990, The Journal of biological chemistry.

[15]  J. R. Cook,et al.  The role of adenosine 3':5'-cyclic monophosphate in the regulation of insulin release by isolated rat islets of Langerhans. , 1971, The Biochemical journal.

[16]  J. Miyazaki,et al.  Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Bos,et al.  Rap1 signalling: adhering to new models , 2001, Nature Reviews Molecular Cell Biology.

[18]  G. Weir,et al.  Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. , 1987, The Journal of clinical investigation.

[19]  Yasuhiro Sunaga,et al.  cAMP-GEFII is a direct target of cAMP in regulated exocytosis , 2000, Nature Cell Biology.

[20]  D. Steiner.  Proinsulin and the biosynthesis of insulin. , 1969, The New England journal of medicine.

[21]  A M Graybiel,et al.  A family of cAMP-binding proteins that directly activate Rap1. , 1998, Science.

[22]  J. Gromada,et al.  Protein Kinase A-Dependent Stimulation of Exocytosis in Mouse Pancreatic β-Cells by Glucose-Dependent Insulinotropic Polypeptide , 1997, Diabetes.

[23]  R. Scheller,et al.  Phosphorylation of synaptic vesicle proteins: modulation of the alpha SNAP interaction with the core complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Habener,et al.  Molecular Basis of Pancreas Development and Function , 2001, Endocrine Updates.

[25]  M. Hussain,et al.  Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element. , 2000, Diabetes.

[26]  D. Kipnis,et al.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects. , 1967, The Journal of clinical investigation.

[27]  J. Holst,et al.  Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1 , 1998, Pflügers Archiv.

[28]  C. Wollheim,et al.  Regulation of insulin release by calcium. , 1981, Physiological reviews.

[29]  H. Elrick,et al.  PLASMA INSULIN RESPONSE TO ORAL AND INTRAVENOUS GLUCOSE ADMINISTRATION. , 1964, The Journal of clinical endocrinology and metabolism.

[30]  J. Brown,et al.  Gastrointestinal Hormones and the Control of Insulin Secretion , 1978, Diabetes.

[31]  G. Holz,et al.  Glucagon-Like Peptide-1: An Insulinotropic Hormone With Potent Growth Factor Actions at the Pancreatic Islets of Langerhans , 2001 .

[32]  A. Wittinghofer,et al.  Mechanism of Regulation of the Epac Family of cAMP-dependent RapGEFs* , 2000, The Journal of Biological Chemistry.

[33]  W. Malaisse,et al.  A possible role for the adenylcyclase system in insulin secretion. , 1967, The Journal of clinical investigation.

[34]  S. Seino,et al.  Hamster gastric inhibitory polypeptide receptor expressed in pancreatic islets and clonal insulin-secreting cells: its structure and functional properties. , 1994, Biochemical and biophysical research communications.

[35]  D. Pipeleers,et al.  Regulation of adenosine 3',5'-monophosphate levels in the pancreatic B cell. , 1985, Endocrinology.

[36]  M. Nelson,et al.  Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2 receptors and cAMP-dependent protein kinase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[37]  H. Rasmussen,et al.  Control of insulin secretion: a model involving Ca2+, cAMP and diacylglycerol , 1990, Molecular and Cellular Endocrinology.

[38]  I. Nishimoto,et al.  Direct control of exocytosis by receptor‐mediated activation of the heterotrimeric GTPases Gi and G(o) or by the expression of their active G alpha subunits. , 1995, The EMBO journal.

[39]  B. Thorens.  Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  N. Nakajima,et al.  Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity. , 1999, Diabetes.

[41]  S. Seino,et al.  PKA‐mediated phosphorylation of the human KATP channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation , 1999, The EMBO journal.

[42]  W. Catterall,et al.  Identification of a 15-kDa cAMP-dependent Protein Kinase-anchoring Protein Associated with Skeletal Muscle L-type Calcium Channels* , 1997, Journal of Biological Chemistry.

[43]  Y. Miyashita,et al.  Post-priming actions of ATP on Ca2+-dependent exocytosis in pancreatic beta cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Meda,et al.  Protein Kinase A-dependent Phosphorylation of GLUT2 in Pancreatic Cells (*) , 1996, The Journal of Biological Chemistry.

[45]  A. Joyner,et al.  Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene , 1996, Nature Medicine.

[46]  L. Eliasson,et al.  Protein kinase A‐dependent and ‐independent stimulation of exocytosis by cAMP in mouse pancreatic B‐cells , 1997, The Journal of physiology.

[47]  L. Langeberg,et al.  Anchoring of protein kinase A facilitates hormone-mediated insulin secretion. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  D. Pipeleers,et al.  Expression and Functional Activity of Glucagon, Glucagon-Like Peptide I, and Glucose-Dependent Insulinotropic Peptide Receptors in Rat Pancreatic Islet Cells , 1996, Diabetes.